Daniel Tillett Insider Profile
25 Followers
Daniel Tillett, Chief Executive Officer & Managing Director, Ten Percent Owner at Race Oncology Ltd., holds 20.29M shares in Race Oncology Ltd. (Ticker: AU:RAC), holds 67.00M shares in Tryptamine Therapeutics (Ticker: AU:ENP), holds 44.19M shares in Simble Solutions Ltd. (Ticker: AU:SIS). Most recently, Daniel Tillett Bought ― shares of Race Oncology Ltd. on Sep 29, 2026 for an estimated value of AU$45.70K.
Daniel Tillett Race Oncology Ltd. (RAC)Chief Executive Officer & Managing Director, Ten Percent Owner
Race Oncology Ltd. (RAC)
Chief Executive Officer & Managing Director, Ten Percent Owner
Ranked #208 out of 109,193 Corporate Insiders
Profitable Transactions
5 out of 18 Profitable Transactions
Average Return
+102.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Tillett holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Tillett
Daniel Tillett's Trading History
Race Oncology Ltd.
Sep 29, 2026
Chief Executive Officer & Managing Director, Ten Percent Owner
Informative Buy
45.70K
AU$39.26M
Simble Solutions Ltd.
Mar 28, 2023
Director
Informative Buy
50.00K
―
Tryptamine Therapeutics
Apr 20, 2026
Director
Informative Buy
170.00K
AU$2.68M
List of latest transactions for each holding click on a transaction to see Daniel Tillett's performance on stock
You May Also Like
Daniel Tillett insider profile FAQ
What is the percentage of profitable transactions made by Daniel Tillett?
The percentage of profitable transactions made by Daniel Tillett is 28%.
What is the average return per transaction made by Daniel Tillett?
The average return per transaction made by Daniel Tillett is 102.30%.
What stocks does Daniel Tillett hold?
Daniel Tillett holds: AU:RAC, AU:SIS, AU:ENP stocks.
What was Daniel Tillett’s latest transaction?
Daniel Tillett latest transaction was an Informative Buy of AU$45.70K.
What was Daniel Tillett's most profitable transaction?
Daniel Tillett’s most profitable transaction was an Informative Buy of AU:RAC stock on December 5, 2019. The return on the trade was 800.00%.
What is Daniel Tillett's role in Race Oncology Ltd.?
Daniel Tillett's role in Race Oncology Ltd. is Chief Executive Officer & Managing Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.